104 related articles for article (PubMed ID: 3100795)
1. Synthesis and gastric antisecretory properties of alpha chain diene derivatives of misoprostol.
Collins PW; Gasiecki AF; Jones PH; Bauer RF; Gullikson GW; Woods EM; Bianchi RG
J Med Chem; 1986 Jul; 29(7):1195-201. PubMed ID: 3100795
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and gastrointestinal pharmacology of a 3E,5Z diene analogue of misoprostol.
Collins PW; Kramer SW; Gasiecki AF; Weier RM; Jones PH; Gullikson GW; Bianchi RG; Bauer RF
J Med Chem; 1987 Jan; 30(1):193-7. PubMed ID: 3100798
[TBL] [Abstract][Full Text] [Related]
3. Alpha chain unsaturated derivatives of misoprostol.
Collins PW; Gasiecki AF; Weier RM; Kramer SW; Jones PH; Gullikson GW; Bianchi RG; Bauer RF
Prostaglandins; 1987; 33 Suppl():17-28. PubMed ID: 3122273
[TBL] [Abstract][Full Text] [Related]
4. Chemistry and structure-activity relationships of C-17 unsaturated 18-cycloalkyl and cycloalkenyl analogues of enisoprost. Identification of a promising new antiulcer prostaglandin.
Collins PW; Gasiecki AF; Perkins WE; Gullikson GW; Bianchi RG; Kramer SW; Ng JS; Yonan EE; Swenton L; Jones PH
J Med Chem; 1990 Oct; 33(10):2784-93. PubMed ID: 2213831
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of acyclic omega chain conjugated diene analogues of enisoprost.
Collins PW; Shone RL; Perkins WE; Gasiecki AF; Kalish VJ; Kramer SW; Bianchi RG
J Med Chem; 1992 Feb; 35(4):694-704. PubMed ID: 1542096
[TBL] [Abstract][Full Text] [Related]
6. Perspective on the gastric antisecretory effects of misoprostol in man.
Dajani EZ
Prostaglandins; 1987; 33 Suppl():68-77. PubMed ID: 3122277
[TBL] [Abstract][Full Text] [Related]
7. 18-cycloalkyl analogues of enisoprost.
Collins PW; Gasiecki AF; Perkins WE; Gullikson GW; Jones PH; Bauer RF
J Med Chem; 1989 May; 32(5):1001-6. PubMed ID: 2709370
[TBL] [Abstract][Full Text] [Related]
8. Chemistry and synthetic development of misoprostol.
Collins PW; Pappo R; Dajani EZ
Dig Dis Sci; 1985 Nov; 30(11 Suppl):114S-117S. PubMed ID: 3932041
[TBL] [Abstract][Full Text] [Related]
9. Cytoprotective and antisecretory properties of a non-diarrheogenic and non-uterotonic prostacyclin analog: U-68,215.
Robert A; Aristoff PA; Wendling MG; Kimball FA; Miller WL; Gorman RR
Prostaglandins; 1985 Oct; 30(4):619-49. PubMed ID: 4081062
[TBL] [Abstract][Full Text] [Related]
10. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
Wilson DE
Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
[TBL] [Abstract][Full Text] [Related]
11. Effects of some natural and synthetic prostaglandins (PGs) on gastric secretion "in vitro".
Adami M; Bertaccini G
Pharmacol Res Commun; 1988 Jul; 20(7):623-4. PubMed ID: 3140254
[No Abstract] [Full Text] [Related]
12. Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid.
Tsai BS; Kessler LK; Stolzenbach J; Schoenhard G; Bauer RF
Dig Dis Sci; 1991 May; 36(5):588-93. PubMed ID: 1850690
[TBL] [Abstract][Full Text] [Related]
13. Is cytoprotection by misoprostol against ethanol-induced gastric mucosal injury in man mediated by somatostatin?
Godiwala T; Agrawal N; Groot K; Arimura A; Dajani EZ
Prostaglandins; 1987; 33 Suppl():130-1. PubMed ID: 2892229
[No Abstract] [Full Text] [Related]
14. Antisecretory activity of misoprostol, its racemates, stereoisomers and metabolites in isolated parietal cells.
Tsai BS; Kessler LK; Collins P; Kramer S; Bauer RF
Prostaglandins; 1987; 33 Suppl():30-9. PubMed ID: 2827238
[TBL] [Abstract][Full Text] [Related]
15. Ionic fluxes induced by topical misoprostol in canine gastric mucosa.
Gana TJ; MacPherson BR; Ng D; Koo J
Can J Physiol Pharmacol; 1989 Apr; 67(4):353-8. PubMed ID: 2503243
[TBL] [Abstract][Full Text] [Related]
16. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
[TBL] [Abstract][Full Text] [Related]
17. Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa.
Gullikson GW; Anglin CP; Kessler LK; Smeach S; Bauer RF; Dajani EZ
Clin Invest Med; 1987 May; 10(3):145-51. PubMed ID: 3113798
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antisecretory and antiulcer activities of derivatives and analogues of 2-(2-pyridyl)tetrahydrothiophene-2-carbothioamide.
Aloup JC; Bouchaudon J; Farge D; James C; Deregnaucourt J; Hardy-Houis M
J Med Chem; 1987 Jan; 30(1):24-9. PubMed ID: 3806600
[TBL] [Abstract][Full Text] [Related]
19. Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
Monk JP; Clissold SP
Drugs; 1987 Jan; 33(1):1-30. PubMed ID: 3102205
[TBL] [Abstract][Full Text] [Related]
20. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
Wilson DE
Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
